지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2019.9
- 수록면
- 124 - 132 (9page)
이용수
초록· 키워드
오류제보하기
Canine adenovirus type 1 (CAV-1) infection results in hepatitis in dogs. In this study, we investigated the biologic and genetic characteristics of the CAV-1 vaccine strain (CAV1V) to improve quality control about CAV vaccine. The identity of CAV1V as CAV-1 was confirmed based on its cytopathic effects and the results of hemagglutination (HA) and immunofluorescence assays, and electron microscopy. The CAV1V strain reached 107.5 TCID50/mL in MDCK cells at 4 days post-inoculation and exhibited hemmagglutination activity of 256 U using guinea pig erythrocytes. Intranuclear fluorescence in the infected cells was observed and typical adenoviruses were observed in electon microscope. CAV1V strain was identified as a CAV-1 strain by nucleotide sequence analysis. In a comparison of the nucleotide sequences of the fiber genes of several CAV strains, CAV1V showed the highest similarity (99.8%) with the GLAXO strain, which was isolated in Canada. Our biological characterization of CAV1V will facilitate quality control of the canine hepatitis vaccine.
목차
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Adenovirus Vectors: Excellent Tools for Vaccine Development
Immune Network
2021 .02
-
Isolation and identification of canine adenovirus type 2 from a naturally infected dog in Korea
Korean Journal of Veterinary Research(대한수의학회지)
2019 .02
-
Development of next generation COVID-19 vaccine using adenovirus vector platform
한국실험동물학회 학술발표대회 논문집
2022 .07
-
Immunogenicity of a new, inactivated canine adenovirus type 2 vaccine for dogs
Clinical and Experimental Vaccine Research
2020 .01
-
Characterization of pathogenicity and transmission ability of canine Influenza virus with partially truncated NS gene and application to vaccine candidate
한국실험동물학회 학술발표대회 논문집
2022 .01
-
Biological and Genetic Characterization of Canine Distemper Virus Vaccine Candidate Named as CD1901-100
JOURNAL OF BACTERIOLOGY AND VIROLOGY
2022 .06
-
Should the COVID-19 Vaccine be Administered Simultaneously with Other Vaccines?
Infection and Chemotherapy
2021 .09
-
[Infectious Disease] Isolation and genetic characterization of canine adenovirus type 2 variant from raccoon dog (Nyctereutes procynoide koresis) in Republic of Korea
Korean Journal of Veterinary Research(대한수의학회지)
2024 .09
-
Immunogenicity of a novel inactivated canine adenovirus type 2 variant vaccine for dogs
Clinical and Experimental Vaccine Research
2024 .07
-
Review of COVID-19 Vaccines and Their Evidence in Older Adults
Annals of geriatric medicine and research
2021 .01
-
Exploring the experience of developing COVID-19 vaccines in Iran
Clinical and Experimental Vaccine Research
2023 .01
-
Vaccines in the United States: a systematic review on history of evolution, regulations, licensing, and future challenges
Clinical and Experimental Vaccine Research
2020 .01
-
A “Prime and Deploy” Strategy for Universal Influenza Vaccine Targeting Nucleoprotein Induces Lung-Resident Memory CD8 T cells
Immune Network
2021 .08
-
Establishment and characterization of six canine hepatocellular carcinoma cell lines
한국실험동물학회 학술발표대회 논문집
2022 .07
-
Incidence and Sero-survey of Canine Adenovirus Type 2 in Various Animal Species
JOURNAL OF BACTERIOLOGY AND VIROLOGY
2018 .09
-
Therapeutic Vaccines and Nucleic Acid Drugs for Cardiovascular Disease
지질·동맥경화학회지
2024 .09
-
Analysis of physical and biological delivery systems for DNA cancer vaccines and their translation to clinical development
Clinical and Experimental Vaccine Research
2024 .04
-
Ongoing Clinical Trials of Vaccines to Fight against COVID-19 Pandemic
Immune Network
2021 .02
-
Adverse events and preventive measures related to COVID-19 vaccines
Clinical and Experimental Emergency Medicine
2021 .09
-
Parenteral, non-live rotavirus vaccine: recent history and future perspective
Clinical and Experimental Vaccine Research
2021 .09
이 논문의 저자 정보
최근 본 자료
댓글(0)
0
UCI(KEPA) : I410-ECN-0101-2019-475-001282433